Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 46708-793

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 46708-793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figue 1 (Venlafaxine 1 Figure)

A dot plot chart depicting fold changes with 90% confidence intervals for various pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine across special populations. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism (poor/extensive metabolizer), age over 60 years, and gender (female/male). The x-axis shows change relative to a reference value from 0 to 3.5.*

FDA Label Image

30 Capsules (Venlafaxine 150mg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Alembic Pharmaceuticals Limited. The label specifies the dosage form as extended-release capsules, oral route, with a package size of 30 capsules. The label includes storage instructions, a barcode, and a reminder that the medication guide should be dispensed to each patient.*

FDA Label Image

Figure 2 (Venlafaxine 2 Figure)

A forest plot chart depicting fold changes and 90% confidence intervals in pharmacokinetic parameters Cmax and AUC for venlafaxine and its O-desmethyl metabolite (ODV) when coadministered with various interacting drugs. The chart compares changes relative to a reference value, listing drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure 3 (Venlafaxine 3 Figure)

A scatter plot chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for various analytes when interacted with specific drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents the change relative to the reference value, ranging from 0 to 2.*

FDA Label Image

30 Capsules (Venlafaxine 37 5mg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg. The oral extended-release capsules are packaged as 30 count, manufactured by Alembic Pharmaceuticals Limited. The label includes dosage form, strength, child-resistant packaging note, and storage instructions alongside barcode and space for lot and expiration dates.*

FDA Label Image

30 Capsules (Venlafaxine 75mg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, in capsule dosage form. The label states the product is manufactured by Alembic Pharmaceuticals Limited and contains 30 capsules. It includes dosage information and storage instructions, with a barcode and space for lot and expiration dates.*

FDA Label Image

Venlafaxine-structure (Venlafaxine Str)

Chemical structure diagram of venlafaxine hydrochloride, showing the molecular components and arrangement associated with the active ingredient venlafaxine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.